Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma

Cancer Immunology, Immunotherapy

Volumn 55, Issue 8, 2006, Pages 910-917

  Zhou, F L ^a   Zhang, W G ^a   Chen, G ^a   Zhao, W H ^a   Cao, X M ^a   Chen, Y X ^a   Tian, W ^a   Liu, J ^a   Liu, S H ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bioinformatics; CrELISA; Multiple myeloma; SEREX; SYBR green real time PCR; Tumor antigen

Indexed keywords

AUTOANTIBODY; RECOMBINANT DNA; TUMOR ANTIGEN;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; BIOINFORMATICS; CANCER IMMUNOTHERAPY; CANCER PATIENT; CARCINOGENESIS; CELL LYSATE; CLONING; CONTROLLED STUDY; DNA LIBRARY; DNMT1 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLJ46859 FIS GENE; GENE; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; KLF10 GENE; MMSA 1 GENE; MMSA 3 GENE; MMSA 7 GENE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; P02 PROTEIN GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RING FINGER PROTEIN 167 GENE; TPT1 GENE;

ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33646346904     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0074-x     Document Type: Article

References (49)

1. Ballen KK, King R, Carston M, Kollman C, Nelson G, Lim S, Reece D, Giralt S, Vesole DH (2005) Outcome of unrelated transplants in patients with multiple myeloma. Bone Marrow Transplant 35:675-681
2. Benjamin M, Reddy S, Brawley OW (2003) Myeloma and race: a review of the literature. Cancer Metastasis Rev 22:87-93
3. Bommer UA, Thiele BJ (2004) The translationally controlled tumour protein (TCTP). Int J Biochem Cell Biol 36:379-385
4. Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A, Boccadoro M (2004) New drugs for treatment of multiple myeloma. Lancet Oncol 5:430-442
5. Caldera H, Giralt S (2004) Stem cell transplantation for multiple myeloma: current status and future directions. Curr Hematol Rep 3:249-256
6. Chen G, Zhang W, Cao X, Li F, Liu X, Yao L (2005) Serological identification of immunogenic antigens in acute monocytic leukemia. Leuk Res 29:503-509
7. Chiambaretta F, De Graeve F, Turet G, Marceau G, Gain P, Dastugue B, Rigal D, Sapin V (2004) Cell and tissue specific expression of human Kruppel-like transcription factors in human ocular surface. Mol Vis 10:901-909
8. Chng WJ, Lau LG, Yusof N, Mow BM (2005) Targeted therapy in multiple myeloma. Cancer Control 12:91-104
9. Chou T (2005) Multiple myeloma - recent advances in diagnosis and treatment. Gan To Kagaku Ryoho 32:304-308
10. del Val C, Mehrle A, Falkenhahn M, Seiler M, Glatting KH, Poustka A, Suhai S, Wiemann S (2004) High-throughput protein analysis integrating bioinformatics and experimental assays. Nucleic Acids Res 32:742-748
11. Desany B, Zhang Z (2004) Bioinformatics and cancer target discovery. Drug Discov Today 9:795-802
12. Di Modugno F, Bronzi G, Scanlan MJ, Del Bello D, Cascioli S, Venturo I, Botti C, Nicotra MR, Mottolese M, Natali PG, Santoni A, Jager E, Nistico P (2004) Human Mena protein, a serex - defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int J Cancer 109:909-918
13. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S (2004) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164:689-699
14. Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG (2004) Expression of Dnmtl, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10:3394-3398
15. Fiucci G, Lespagnol A, Stumptner-Cuvelette P, Beaucourt S, Duflaut D, Susini L, Amson R, Telerman A (2003) Genomic organization and expression of mouse Tpt1 gene. Genomics 81:570-578
16. Granfar RM, Day CJ, Kim MS, Morrison NA (2005) Optimised real-time quantitative PCR assays for RANKL regulated genes. Mol Cell Probes 19:119-126
17. Iwata T, Fujita T, Hirao N, Matsuzaki Y, Okada T, Mochimaru H, Susumu N, Matsumoto E, Sugano K, Yamashita N, Nozawa S, Kawakami Y (2005) Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer. Clin Cancer Res 11:3949-3957
18. Jager D, Taverna C, Zippelius A, Knuth A (2004) Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol Immunother 53:144-147
19. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fossa A (2004) Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2. Cancer Immunol Immunother 53:1119-1126
20. Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR (2004) Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc 79:867-874
21. Langer F, Dingemann J, Kreipe H, Lehmann U (2005) Upregulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndrome. Leuk Res 29:325-329
22. Li G, Miles A, Line A, Rees RC (2004) Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunol Immunother 53:139-143
23. Liggins AP, Guinn BA, Hatton CS, Pulford K, Banham AH (2004) Serologic detection of diffuse large B-cell lymphoma-associated antigens. Int J Cancer 110:563-569
24. Lotz C, Mutallib SA, Oehlrich N, Liewer U, Ferreira EA, Moos M, Hundemer M, Schneider S, Strand S, Huber C, Goldschmidt H, Theobald M (2005) Targeting positive regulatory domain i-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL. J Immunol 175:1301-1309
25. MacDonald SM, Paznekas WA, Jabs EW (1999) Chromosomal localization of tumor protein, translationally-controlled 1 (TPT1) encoding the human histamine releasing factor (HRF) to 13q12 → q14. Cytogenet Cell Genet 84:128-129
26. Morse DL, Carroll D, Weberg L, Borgstrom MC, Ranger-Moore J, Gillies RJ (2005) Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 342:69-77
27. Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y, Kotani H (1995) Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res 2:37-43
28. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S (2005) DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J Urol 173:1767-1771
29. Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K (2002) Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur J Immunol 32:826-836
30. Passoni L, Gambacorti-Passerini C (2003) ALK a novel lymphoma-associated tumor antigen for vaccination strategies. Leuk Lymphoma 44:1675-1681
31. Pavoni E, Vaccaro P, Pucci A, Monteriu G, Beghetto E, Barca S, Dupuis ML, De Pasquale Ceratti A, Lugini A, Cianfriglia M, Cortesi E, Felici F, Minenkova O (2004) Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage. BMC Cancer 4:78
32. Podar K, Hideshima T, Chauhan D, Anderson KC (2005)Targeting signalling pathways for the treatment of multiple myeloma. Expert Opin Ther Targets 9:359-381
33. Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M (2002) Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 188:43-50
34. Qayum I, Ashraf M (2004) Increased DNA methyltransferase 1 (DNMT1) gene expression in human lymphomas by fluorescent in situ hybridization. J Ayub Med Coll Abbottabad 16:1-6
35. Qian F, Odunsi K, Blatt LM, Scanlan MJ, Mannan M, Shah N, Montgomery J, Haddad F, Taylor M (2005) Tumor associated antigen recognition by autologous serum in patients with breast cancer. Int J Mol Med 15:137-144
36. Radford KJ, Turtle CJ, Kassianos AJ, Vuckovic S, Gardiner D, Khalil D, Taylor K, Wright S, Gill D, Hart DN (2005) Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. J Immunother 28:322-331
37. Ren SP, Wu CT, Huang WR, Lu ZZ, Jia XX, Wang L, Lao MF, Wang LS (2005) Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro. Cancer Immunol Immunother 54:1-11
38. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810-11813
39. Sanda T, Iida S, Ogura H, Asamitsu K, Murata T, Bacon KB, Ueda R, Okamoto T (2005) Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. Clin Cancer Res 11:1974-1982
40. Shi YY, Wang HC, Yin YH, Sun WS, Li Y, Zhang CQ, Wang Y, Wang S, Chen WF (2005) Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. Br J Cancer 92:929-934
41. Shichijo S, Ishihara Y, Azuma K, Komatsu N, Higashimoto N, Ito M, Nakamura T, Ueno T, Harada M, Itoh K (2005) ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients. Oncol Rep 13:907-913
42. Shimada H, Nakashima K, Ochiai T, Nabeya Y, Takiguchi M, Nomura F, Hiwasa T (2005) Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 26:77-86
43. Shimizu K, Nagura E, Takatsuki K, Japan Myeloma Study Group (2004) Management of patients with multiple myeloma in Japan: data of 1,383 patients from 16 hospitals and one treatment group. Leuk Lymphoma 45:2465-2469
44. Tai YT, Li X, Tong X, Santos D, Otsuki T, Catley L, Tournilhac O, Podar K, Hideshima T, Schlossman R, Richardson P, Munshi NC, Luqman M, Anderson KC (2005) Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma. Cancer Res 65:5898-5906
45. Takedatsu H, Yoshimoto K, Okamura T, Yakushij K, Imamura R, Hashiguchi M, Seki R, Obata Y, Harada M, Yamada A, Yamana H, Sata M, Itoh K (2005) Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy. Int J Oncol 26:1605-1612
46. Thomson KJ, Peggs KS (2005) Role of allogeneic stem cell transplantation in multiple myeloma. Expert Rev Anticancer Ther 5:455-464
47. Tureci O, Luxemburger U, Heinen H, Mack U, Sybrecht GW, Huber C, Sahin U (2004) CrELISA: a fast and robust enzyme-linked immunosorbant assay bypassing the need for purification of recombinant protein. J Immunol Methods 289:191-199
48. Wang Y, Gu Q, Liu B, Zhu Z (2004) Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer. Cancer Biol Ther 3:806-811
49. Yokochi T, Robertson KD (2004) Doxorubicin inhibits DNMT1, resulting in conditional apoptosis. Mol Pharmacol 66:1415-1420